Global Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03240914

Publication Date:

March 1, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Molecular Diagnostics market size was valued at US$ 625.3 million in 2023. With growing demand in downstream market, the Molecular Diagnostics is forecast to a readjusted size of US$ 934.8 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Molecular Diagnostics market. Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molecular Diagnostics market.
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.
Key Features:
The report on Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Real Time- PCR Systems, Liquid Handling System), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Molecular Diagnostics industry. This include advancements in Molecular Diagnostics technology, Molecular Diagnostics new entrants, Molecular Diagnostics new investment, and other innovations that are shaping the future of Molecular Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Molecular Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molecular Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molecular Diagnostics market.
Market Segmentation:
Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Real Time- PCR Systems
Liquid Handling System
NA Extraction System
Segmentation by application
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Market Size 2019-2030
2.1.2 Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Diagnostics Segment by Type
2.2.1 Real Time- PCR Systems
2.2.2 Liquid Handling System
2.2.3 NA Extraction System
2.3 Molecular Diagnostics Market Size by Type
2.3.1 Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Molecular Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Academic and Research Institutes
2.4.4 Pharmaceutical and Biotechnology Companies
2.5 Molecular Diagnostics Market Size by Application
2.5.1 Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular Diagnostics Market Size Market Share by Application (2019-2024)
3 Molecular Diagnostics Market Size by Player
3.1 Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Diagnostics by Regions
4.1 Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Diagnostics by Country (2019-2024)
7.2 Europe Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Diagnostics Market Forecast
10.1 Global Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Molecular Diagnostics Forecast
10.1.3 APAC Molecular Diagnostics Forecast
10.1.4 Europe Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Forecast
10.2 Americas Molecular Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Molecular Diagnostics Market Forecast
10.2.2 Canada Molecular Diagnostics Market Forecast
10.2.3 Mexico Molecular Diagnostics Market Forecast
10.2.4 Brazil Molecular Diagnostics Market Forecast
10.3 APAC Molecular Diagnostics Forecast by Region (2025-2030)
10.3.1 China Molecular Diagnostics Market Forecast
10.3.2 Japan Molecular Diagnostics Market Forecast
10.3.3 Korea Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Market Forecast
10.3.5 India Molecular Diagnostics Market Forecast
10.3.6 Australia Molecular Diagnostics Market Forecast
10.4 Europe Molecular Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Molecular Diagnostics Market Forecast
10.4.2 France Molecular Diagnostics Market Forecast
10.4.3 UK Molecular Diagnostics Market Forecast
10.4.4 Italy Molecular Diagnostics Market Forecast
10.4.5 Russia Molecular Diagnostics Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Molecular Diagnostics Market Forecast
10.5.2 South Africa Molecular Diagnostics Market Forecast
10.5.3 Israel Molecular Diagnostics Market Forecast
10.5.4 Turkey Molecular Diagnostics Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Market Forecast
10.6 Global Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global Molecular Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Molecular Diagnostics Product Offered
11.1.3 Agilent Technologies Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Molecular Diagnostics Product Offered
11.2.3 BD Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Molecular Diagnostics Product Offered
11.3.3 Bio-Rad Laboratories Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Molecular Diagnostics Product Offered
11.4.3 Danaher Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche Molecular Diagnostics Product Offered
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Eppendorf
11.6.1 Eppendorf Company Information
11.6.2 Eppendorf Molecular Diagnostics Product Offered
11.6.3 Eppendorf Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eppendorf Main Business Overview
11.6.5 Eppendorf Latest Developments
11.7 PerkinElmer
11.7.1 PerkinElmer Company Information
11.7.2 PerkinElmer Molecular Diagnostics Product Offered
11.7.3 PerkinElmer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 PerkinElmer Main Business Overview
11.7.5 PerkinElmer Latest Developments
11.8 Tecan Group
11.8.1 Tecan Group Company Information
11.8.2 Tecan Group Molecular Diagnostics Product Offered
11.8.3 Tecan Group Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Tecan Group Main Business Overview
11.8.5 Tecan Group Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Molecular Diagnostics Product Offered
11.9.3 Thermo Fisher Scientific Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Information
11.10.2 QIAGEN Molecular Diagnostics Product Offered
11.10.3 QIAGEN Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 QIAGEN Main Business Overview
11.10.5 QIAGEN Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂